The mobile cardiac telemetry systems market size has grown strongly in recent years. It will grow from $1.06 billion in 2025 to $1.16 billion in 2026 at a compound annual growth rate (CAGR) of 10%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, growing incidence of arrhythmias, limitations of traditional holter monitoring, increasing aging population, expanding use of outpatient cardiac diagnostics.
The mobile cardiac telemetry systems market size is expected to see strong growth in the next few years. It will grow to $1.7 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to growing adoption of remote patient monitoring, increasing demand for early cardiac event detection, expansion of home-based healthcare services, rising focus on continuous real-time cardiac data, improving access to digital cardiac care solutions. Major trends in the forecast period include rising adoption of continuous remote cardiac monitoring, growing shift toward ambulatory and home-based cardiac care, increasing use of patch-based cardiac telemetry devices, expansion of real-time arrhythmia detection and alert systems, growing demand for long-term cardiac rhythm monitoring.
The increasing incidence of cardiovascular disease is anticipated to drive the growth of the mobile cardiac telemetry systems market in the future. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and hypertension, which can result in severe health complications such as heart attacks, strokes, and other cardiovascular events. The prevalence of cardiovascular disease is rising due to growing risk factors such as sedentary lifestyles, poor diets, obesity, and aging populations. Mobile cardiac telemetry systems provide continuous, real-time monitoring and early detection of cardiac arrhythmias in patients with cardiovascular conditions. For example, in January 2024, the American Heart Association, a US-based nonprofit organization, reported a slight increase in cardiovascular-related deaths this year, reaching 931,578, a marginal rise of 3,000 compared to the previous year's total of 928,741. Consequently, the rising incidence of cardiovascular disease is fueling the growth of the mobile cardiac telemetry systems market.
Leading companies in the mobile cardiac telemetry systems market are developing innovative solutions, such as advanced wearable ECG devices, to improve real-time cardiac data accuracy and support remote patient management. ECG devices are medical instruments that record the heart’s electrical activity to detect and monitor cardiovascular conditions. For example, in October 2023, Biotricity Inc., a US-based medical diagnostics company, launched BioTresPro, a next-generation three-channel wearable cardiac monitoring device designed for continuous real-time telemetry. The system features integrated cellular backup for reliable data transmission, continuous multi-lead ECG acquisition for enhanced signal quality, and improved remote connectivity that ensures uninterrupted monitoring even in areas with limited coverage. These capabilities enable clinicians to detect critical cardiac events more quickly and make faster care decisions for patients under ambulatory monitoring.
In May 2024, WearLinq, Inc., a US-based healthcare technology company, acquired AMI Cardiac Monitoring LLC for $6.7 million. Through this acquisition, WearLinq aims to significantly expand its clinical service offerings and enhance cardiac diagnostic capabilities across the United States. AMI Cardiac Monitoring LLC specializes in providing remote cardiac monitoring services.
Major companies operating in the mobile cardiac telemetry systems market are Medtronic PLC, Philips Healthcare, Boston Scientific Corporation, iRhythm Technologies Inc., Biotricity Inc., Zoll Medical Corporation, Spacelabs Healthcare, Infobionic Inc., Medicomp Inc., ScottCare Corporation, Medicalgorithmics S.A., Ambucor Health Solutions Inc., Telerhythmics LLC, Vitaphone GmbH, Card Guard, Heart Test Laboratories Inc., Reactdx, Nuvant Health, Bittium Corporation, Fukuda Denshi Co Ltd, GE HealthCare, Mindray Medical International.
North America was the largest region in the mobile cardiac telemetry systems market in 2025. The regions covered in the mobile cardiac telemetry systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mobile cardiac telemetry systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the mobile cardiac telemetry systems market by increasing costs for imported electronic components, sensors, and wireless communication modules. These impacts are most prominent in north america and asia-pacific, where telemetry device manufacturing relies on global supply chains. Higher costs have influenced pricing for hospitals, cardiac centers, and home care providers. However, tariffs have also encouraged localized manufacturing, component sourcing diversification, and investment in domestic production capabilities, supporting long-term supply stability.
The mobile cardiac telemetry systems market research report is one of a series of new reports that provides mobile cardiac telemetry systems market statistics, including mobile cardiac telemetry systems industry global market size, regional shares, competitors with a mobile cardiac telemetry systems market share, detailed mobile cardiac telemetry systems market segments, market trends and opportunities, and any further data you may need to thrive in the mobile cardiac telemetry systems industry. This mobile cardiac telemetry systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Mobile cardiac telemetry systems are sophisticated devices used for real-time detection and recording of abnormal heart rhythms. They continuously monitor a patient’s heart activity and automatically send data to a central monitoring center. This enables prompt analysis and timely intervention by healthcare professionals. MCT systems are commonly employed for diagnosing and managing arrhythmias and other cardiac conditions.
The primary types of mobile cardiac telemetry systems are multiple lead mobile cardiac telemetry systems and mobile cardiac telemetry patches. Multiple lead mobile cardiac telemetry systems utilize several electrodes attached to a patient's body to continuously monitor heart activity. These systems are used for detecting cardiovascular diseases, angina pectoris, atherosclerosis, heart failure, and other conditions. They are employed by a range of end-users, including hospitals, cardiac centers, home care settings, and more.
The mobile cardiac telemetry systems market consists of sales of wearable sensors, transmitter devices, and data transmission units. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The mobile cardiac telemetry systems market size is expected to see strong growth in the next few years. It will grow to $1.7 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to growing adoption of remote patient monitoring, increasing demand for early cardiac event detection, expansion of home-based healthcare services, rising focus on continuous real-time cardiac data, improving access to digital cardiac care solutions. Major trends in the forecast period include rising adoption of continuous remote cardiac monitoring, growing shift toward ambulatory and home-based cardiac care, increasing use of patch-based cardiac telemetry devices, expansion of real-time arrhythmia detection and alert systems, growing demand for long-term cardiac rhythm monitoring.
The increasing incidence of cardiovascular disease is anticipated to drive the growth of the mobile cardiac telemetry systems market in the future. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and hypertension, which can result in severe health complications such as heart attacks, strokes, and other cardiovascular events. The prevalence of cardiovascular disease is rising due to growing risk factors such as sedentary lifestyles, poor diets, obesity, and aging populations. Mobile cardiac telemetry systems provide continuous, real-time monitoring and early detection of cardiac arrhythmias in patients with cardiovascular conditions. For example, in January 2024, the American Heart Association, a US-based nonprofit organization, reported a slight increase in cardiovascular-related deaths this year, reaching 931,578, a marginal rise of 3,000 compared to the previous year's total of 928,741. Consequently, the rising incidence of cardiovascular disease is fueling the growth of the mobile cardiac telemetry systems market.
Leading companies in the mobile cardiac telemetry systems market are developing innovative solutions, such as advanced wearable ECG devices, to improve real-time cardiac data accuracy and support remote patient management. ECG devices are medical instruments that record the heart’s electrical activity to detect and monitor cardiovascular conditions. For example, in October 2023, Biotricity Inc., a US-based medical diagnostics company, launched BioTresPro, a next-generation three-channel wearable cardiac monitoring device designed for continuous real-time telemetry. The system features integrated cellular backup for reliable data transmission, continuous multi-lead ECG acquisition for enhanced signal quality, and improved remote connectivity that ensures uninterrupted monitoring even in areas with limited coverage. These capabilities enable clinicians to detect critical cardiac events more quickly and make faster care decisions for patients under ambulatory monitoring.
In May 2024, WearLinq, Inc., a US-based healthcare technology company, acquired AMI Cardiac Monitoring LLC for $6.7 million. Through this acquisition, WearLinq aims to significantly expand its clinical service offerings and enhance cardiac diagnostic capabilities across the United States. AMI Cardiac Monitoring LLC specializes in providing remote cardiac monitoring services.
Major companies operating in the mobile cardiac telemetry systems market are Medtronic PLC, Philips Healthcare, Boston Scientific Corporation, iRhythm Technologies Inc., Biotricity Inc., Zoll Medical Corporation, Spacelabs Healthcare, Infobionic Inc., Medicomp Inc., ScottCare Corporation, Medicalgorithmics S.A., Ambucor Health Solutions Inc., Telerhythmics LLC, Vitaphone GmbH, Card Guard, Heart Test Laboratories Inc., Reactdx, Nuvant Health, Bittium Corporation, Fukuda Denshi Co Ltd, GE HealthCare, Mindray Medical International.
North America was the largest region in the mobile cardiac telemetry systems market in 2025. The regions covered in the mobile cardiac telemetry systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mobile cardiac telemetry systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the mobile cardiac telemetry systems market by increasing costs for imported electronic components, sensors, and wireless communication modules. These impacts are most prominent in north america and asia-pacific, where telemetry device manufacturing relies on global supply chains. Higher costs have influenced pricing for hospitals, cardiac centers, and home care providers. However, tariffs have also encouraged localized manufacturing, component sourcing diversification, and investment in domestic production capabilities, supporting long-term supply stability.
The mobile cardiac telemetry systems market research report is one of a series of new reports that provides mobile cardiac telemetry systems market statistics, including mobile cardiac telemetry systems industry global market size, regional shares, competitors with a mobile cardiac telemetry systems market share, detailed mobile cardiac telemetry systems market segments, market trends and opportunities, and any further data you may need to thrive in the mobile cardiac telemetry systems industry. This mobile cardiac telemetry systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Mobile cardiac telemetry systems are sophisticated devices used for real-time detection and recording of abnormal heart rhythms. They continuously monitor a patient’s heart activity and automatically send data to a central monitoring center. This enables prompt analysis and timely intervention by healthcare professionals. MCT systems are commonly employed for diagnosing and managing arrhythmias and other cardiac conditions.
The primary types of mobile cardiac telemetry systems are multiple lead mobile cardiac telemetry systems and mobile cardiac telemetry patches. Multiple lead mobile cardiac telemetry systems utilize several electrodes attached to a patient's body to continuously monitor heart activity. These systems are used for detecting cardiovascular diseases, angina pectoris, atherosclerosis, heart failure, and other conditions. They are employed by a range of end-users, including hospitals, cardiac centers, home care settings, and more.
The mobile cardiac telemetry systems market consists of sales of wearable sensors, transmitter devices, and data transmission units. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Mobile Cardiac Telemetry Systems Market Characteristics
3. Mobile Cardiac Telemetry Systems Market Supply Chain Analysis
4. Global Mobile Cardiac Telemetry Systems Market Trends and Strategies
5. Mobile Cardiac Telemetry Systems Market Analysis of End Use Industries
7. Global Mobile Cardiac Telemetry Systems Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Mobile Cardiac Telemetry Systems Total Addressable Market (TAM) Analysis for the Market
9. Mobile Cardiac Telemetry Systems Market Segmentation
10. Mobile Cardiac Telemetry Systems Market Regional and Country Analysis
11. Asia-Pacific Mobile Cardiac Telemetry Systems Market
12. China Mobile Cardiac Telemetry Systems Market
13. India Mobile Cardiac Telemetry Systems Market
14. Japan Mobile Cardiac Telemetry Systems Market
15. Australia Mobile Cardiac Telemetry Systems Market
16. Indonesia Mobile Cardiac Telemetry Systems Market
17. South Korea Mobile Cardiac Telemetry Systems Market
18. Taiwan Mobile Cardiac Telemetry Systems Market
19. South East Asia Mobile Cardiac Telemetry Systems Market
20. Western Europe Mobile Cardiac Telemetry Systems Market
21. UK Mobile Cardiac Telemetry Systems Market
22. Germany Mobile Cardiac Telemetry Systems Market
23. France Mobile Cardiac Telemetry Systems Market
24. Italy Mobile Cardiac Telemetry Systems Market
25. Spain Mobile Cardiac Telemetry Systems Market
26. Eastern Europe Mobile Cardiac Telemetry Systems Market
27. Russia Mobile Cardiac Telemetry Systems Market
28. North America Mobile Cardiac Telemetry Systems Market
29. USA Mobile Cardiac Telemetry Systems Market
30. Canada Mobile Cardiac Telemetry Systems Market
31. South America Mobile Cardiac Telemetry Systems Market
32. Brazil Mobile Cardiac Telemetry Systems Market
33. Middle East Mobile Cardiac Telemetry Systems Market
34. Africa Mobile Cardiac Telemetry Systems Market
36. Mobile Cardiac Telemetry Systems Market Competitive Landscape and Company Profiles
37. Mobile Cardiac Telemetry Systems Market Other Major and Innovative Companies
40. Mobile Cardiac Telemetry Systems Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Mobile Cardiac Telemetry Systems Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses mobile cardiac telemetry systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for mobile cardiac telemetry systems? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mobile cardiac telemetry systems market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Multiple Lead Mobile Cardiac Telemetry Systems; Mobile Cardiac Telemetry Patch2) By Monitoring & Service Model: Continuous Real-Time Monitoring; Intermittent or Event-Triggered Monitoring; Prescription-Based Remote Patient Monitoring Platforms; Managed or Outsourced Monitoring Services; Device-as-a-Service or Subscription-Based Models; Hybrid Monitoring Models
3) By End-Use: Hospitals; Cardiac Centers; Home Care Settings; Other End-Uses
Subsegments:
1) By Multiple Lead Mobile Cardiac Telemetry Systems: Wired Multiple Lead Systems; Wireless Multiple Lead Systems2) By Mobile Cardiac Telemetry Patch: Adhesive Patches; Disposable Patches
Companies Mentioned: Medtronic PLC; Philips Healthcare; Boston Scientific Corporation; iRhythm Technologies Inc.; Biotricity Inc.; Zoll Medical Corporation; Spacelabs Healthcare; Infobionic Inc.; Medicomp Inc.; ScottCare Corporation; Medicalgorithmics S.A.; Ambucor Health Solutions Inc.; Telerhythmics LLC; Vitaphone GmbH; Card Guard; Heart Test Laboratories Inc.; Reactdx; Nuvant Health; Bittium Corporation; Fukuda Denshi Co Ltd; GE HealthCare; Mindray Medical International
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Mobile Cardiac Telemetry Systems market report include:- Medtronic PLC
- Philips Healthcare
- Boston Scientific Corporation
- iRhythm Technologies Inc.
- Biotricity Inc.
- Zoll Medical Corporation
- Spacelabs Healthcare
- Infobionic Inc.
- Medicomp Inc.
- ScottCare Corporation
- Medicalgorithmics S.A.
- Ambucor Health Solutions Inc.
- Telerhythmics LLC
- Vitaphone GmbH
- Card Guard
- Heart Test Laboratories Inc.
- Reactdx
- Nuvant Health
- Bittium Corporation
- Fukuda Denshi Co Ltd
- GE HealthCare
- Mindray Medical International
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.16 Billion |
| Forecasted Market Value ( USD | $ 1.7 Billion |
| Compound Annual Growth Rate | 9.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
